MC2 to recruit first patients for proof-of-concept clinical trial with new candidate
A total of 40 patients will be recruited and data from the study will determine the study design for a larger phase IIb trial.
MC2 has now enrolled the first patients in a newly initiated Phase II study with the candidate, MC2-25 VLS, the company writes in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Pipeline hope shows promise for MC2 Therapeutics
For subscribers
